Nickolas Kontorinis
About
In The Last Decade
Nickolas Kontorinis
21 papers receiving 499 citations
Peers
Comparison fields: 5 of 55
- Hepatology 353
- Epidemiology 316
- Infectious Diseases 108
- Surgery 83
- Virology 51
Countries citing papers authored by Nickolas Kontorinis
This map shows the geographic impact of Nickolas Kontorinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nickolas Kontorinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nickolas Kontorinis more than expected).
Fields of papers citing papers by Nickolas Kontorinis
This network shows the impact of papers produced by Nickolas Kontorinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nickolas Kontorinis. The network helps show where Nickolas Kontorinis may publish in the future.
Co-authorship network of co-authors of Nickolas Kontorinis
This figure shows the co-authorship network connecting the top 25 collaborators of Nickolas Kontorinis. A scholar is included among the top collaborators of Nickolas Kontorinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nickolas Kontorinis. Nickolas Kontorinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Treatment and outcomes of patients with autoimmune overlap syndromes | 1 |
| 2 | 8 | |
| 3 | 44 | |
| 4 | 23 | |
| 5 | 22 | |
| 6 | 1 | |
| 7 | 36 | |
| 8 | 2 | |
| 9 | 54 | |
| 10 | 66 | |
| 11 | 45 | |
| 12 | 3 | |
| 13 | 9 | |
| 14 | HIV/HCV coinfection in clinical practice. | 4 |
| 15 | 10 | |
| 16 | 10 | |
| 17 | Current status of the use of growth factors and other adjuvant medications in patients receiving peginterferon and ribavirin. | 12 |
| 18 | 65 | |
| 19 | Hepatotoxicity of antiretroviral therapy. | 78 |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.